focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProgility Regulatory News (PGY)

  • There is currently no data for PGY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

29 Mar 2018 07:00

RNS Number : 3175J
Progility PLC
29 March 2018
 

29 March 2018

 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

Progility plc

("Progility" or "the Group")

Interim Results

Progility plc (AIM: PGY) the Professional Services, Healthcare and Communications firm is pleased to announce its Interim Results for the six months to 31 December 2017.

The results for the six months to 31 December 2017 have shown a decrease in sales, down by 8.9% over the first half of last year. The businesses' performance continues to be reported in three segments; Professional Services (comprising the training and recruitment businesses), Healthcare (comprising Starkstrom) and Communications (which is comprised of our communications technology businesses in India and Australia). Professional Services revenues decreased in the period by 7.9% and Communications by 13.6%, whilst Healthcare increased 3.2%.

 

Highlights from continuing operations

· Revenues down 8.9% to £33.2 million (2016: £36.4 million)

· Reported Operating profit before one-off items £1.0 million (2016: £1.6 million)

· One-off items incurred - project overruns in Healthcare (£0.37 million)) and one-off consultancy costs (£0.2 million)

· Operating profit before one-off items £1.6 million (2016: £1.6 million)

· Loss before tax £0.9 million (2016: Profit before tax £0.03 million)

· Gross profit margin of 34.0% (2016: 34.9%)

· Operating profit margin of 3.0% (2016: 4.5%)

· Impact of FX year on year is minimal on sales and on operating loss

· Further reduction in Central corporate costs

 

 

Wayne Bos, Executive Chairman, commented:

"The last six months have seen a slight decline in the performance of the Group as a whole. Gross profit margins have fallen compared to the previous year, due to one-off items, however improved efficiencies and savings in Central corporate costs have reduced the decrease in the operating profit margin.

In my statement in the 2017 Annual Report I referred to a focus during the current financial year on embedding greater operational controls and efficiencies, which might cause our progress to be held back in the current year. During the first half of the year, the Group incurred one-off costs totalling £568k, of which £364k arose in Healthcare and relates to historic contracts which were not adequately specified and which our improved operational controls would not have permitted.

Overall, without these costs, gross margins would have been maintained at 35.1% (2016: 34.9%) and operating profit would have been £1.6m (2016: £1.6m).

In Professional Services, revenue increased in the ILX business in UK, Australia and New Zealand, but fell in the Middle East. Revenue fell in the recruitment businesses. Overall operating profitability fell from £0.74m to £0.58m.

 

The UK-based Starkstrom Healthcare business increased revenue 3.2% to £6.4m, but operating profits have fallen to £0.014m. There have been significant changes in the senior management team at Starkstrom, leading to increased recruitment and one-off consultancy costs of £153k. Starkstrom also incurred £364k of costs on project overruns. Without these one-off costs, Starkstrom's financial performance would have been broadly the same as last financial year. The new team has reviewed all aspects of the business and has taken steps in early 2018 to reduce costs.

 

In Communications, revenue has fallen by 13.6% and operating profit by 22.7%. Australia's revenue is down 12.3% whilst operating profit is up 65%. This has been achieved through significant reduction in staff costs. A new senior management team has been appointed along with an experienced management consultant.

 

India's revenue is down 14.5%, due largely to the impact of the introduction of GST in July 2017. At the same time gross profit margin has increased by 1.9% and overheads have been tightly controlled. Operating profit margin has fallen from 5% to 2.6% as result of the revenue shortfall. The second half of the year may be impacted by exceptional redundancy costs estimated at $300k AUD.

 

Central corporate costs have been reduced by 29.2% from the prior year, a direct result of measures taken to reduce corporate activity and greater efficiencies in the management of the group.

Overall, we will continue to pursue our strategic objectives, seek means to reduce costs and increase revenues, and to improve performance across all areas of the business. There have been important changes in the leadership of the individual businesses which will drive forward positive changes in performance.

The second half of the year is expected to be impacted by the continuing focus on operational controls and efficiencies. The changes in the leadership in the individual business units are however not expected to show benefits until the next financial year."

 

Enquiries:

Progility plc

 

Wayne Bos, Executive Chairman

020 7371 4444

 

 

SPARK Advisory Partners Limited (Nominated Advisor)

 

Mark Brady/Andrew Emmott

0203 368 3551

 

 

W H Ireland Limited (Broker)

 

Adrian Hadden

020 7220 1666

 

 

Executive Chairman and Financial Review

Introduction

The results for the six months to 31 December 2017 have shown a decrease in sales, down by 8.9% over the prior period. The businesses' performance continues to be reported in three segments; Professional Services (comprising the training and recruitment businesses), Healthcare (comprising Starkstrom) and Communications (which is comprised of our communications technology businesses in India and Australia). Professional Services revenues decreased in the period by 7.9% and Communications by 13.6%, whilst Healthcare increased 3.2%.

 

Highlights from continuing operations

· Revenues down 8.9% to £33.2 million (2016: £36.4 million)

· Reported Operating profit before one-off items £1.0 million (2016: £1.6 million)

· One-off items incurred - project overruns in Healthcare (£0.37 million) and one-off consultancy costs (£0.2 million)

· Operating profit before one-off items £1.6 million (2016: £1.6 million)

· Loss before tax £0.9 million (2016: Profit before tax £0.028 million)

· Gross profit margin of 34.0% (2016: 34.9%)

· Operating profit margin of 3.0% (2016: 4.5%)

· Impact of FX year on year is minimal on sales and on operating loss

· Further reduction in Central corporate costs

 

Overview and summary of results

The last six months have seen a slight decline in the performance of the Group as a whole. Gross profit margins have fallen compared to the previous year, due to one-off items, however improved efficiencies and savings in Central corporate costs have reduced the decrease in the operating profit margin.

In my statement in the 2017 Annual Report I referred to a focus during the current financial year on embedding greater operational controls and efficiencies, which might cause our progress to be held back in the current year. During the first half of the year, the group incurred one-off costs totalling £568k, of which £364k arose in Healthcare and relates to historic contracts which were not adequately specified and which our improved operational controls would not have permitted.

Overall, without these costs, gross margins would have been maintained at 35.1% (2016: 34.9%) and operating profit would have been £1.6m (2016: £1.6m).

Market conditions have improved in Australia, and the Indian operations continue to deliver positive results, despite the impact of fiscal changes (GST) introduced in July 2017 There are challenges to face in Professional Services where revenue has fallen by 7.9%. The current period saw no acquisitions or disposals, thereby allowing the management to focus on the existing businesses and their individual operating performance. Starkstrom in the Health sector has slightly improved in revenue but not in profit terms.

The geographic spread of our Group has been helpful to a developing business, particularly in the digital age; it allows access for our offerings to more markets, as is clearly illustrated with the international spread of the project management training business.

Our business continues to be managed through three business segments to maximize our ability to communicate and to deliver our full range of products and expertise to our key clients' decision makers across the diverse territories and time zones in which we operate. These three segments reflect the management responsibility and accounting arrangements used to manage and report upon the performance of the business. Key performance indicators (KPIs) for each business are revenue, gross profit margin and earnings before interest, taxation, depreciation and amortisation (EBITDA).

 

Summary of results and operating performance from continuing operations

The table below sets out a summary of our results:

 

 

 

 Unaudited six

Unaudited six

 

 

 

 

 months ended

months ended

 

 

 

 

 31 December 2017

 31 December 2016

 

 

 

 

£000

£000

 

Revenue

 

 

33,244

36,486

 

Gross profit

 

 

11,327

12,736

 

Operating profit

1,007

1,628

 

 

Net finance costs

 

(1,816)

(1,600)

 

 

Profit / (loss) before tax

 

(809)

28

 

 

 

 

 

 

 

 

 

Professional Services

Professional Services' revenues declined 7.9% against prior year, from £7.72m to £7.11m. Revenue increased in the ILX business in UK, Australia and New Zealand but fell in the Middle East. Revenue fell in the recruitment businesses. Overall operating profitability fell from £0.74m to £0.58m.

 

Revenue declined in the current period, a result of pricing pressures in the UK ILX business and also a decline in the knowledge information management sector of the recruitment market. Further afield the ILX Australian and New Zealand based businesses reported improvement in both revenues and profits whilst the Dubai business declined.

 

Healthcare

The UK-based Starkstrom Healthcare business increased revenue 3.2% to £6.4m, but operating profits have fallen to £0.014m. There have been significant changes in the senior management team at Starkstrom, leading to increased recruitment and consultancy costs of £153k. Starkstrom also incurred £364k of costs on project overruns. Without these one-off costs, Starkstrom's financial performance would have been broadly the same as last financial year. The new team has reviewed all aspects of the business and has taken steps in early 2018 to reduce costs.

 

Communications

Revenue has fallen 13.6% to £19.7m and 22.7% in operating profit terms to £0.6m compared to the prior period.

Australia's revenue is down 12.3% whilst operating profit is up 65%. This has been achieved through significant reduction in staff costs. A new senior management team has been appointed along with an experienced management consultant.

 

India's revenue is down 14.5%, largely due to the impact of the introduction of GST in July 2017. At the same time gross profit margin has increased by 1.9% and overheads have been tightly controlled. Operating profit margin has fallen from 5% to 2.6% as result of the revenue shortfall.

 

Central corporate costs have been reduced by 29.2% from the prior year, a direct result of measures taken to reduce corporate activity and greater efficiencies in the management of the Group. Central corporate costs totalled £0.4m in the period, compared to £0.57m in the prior year, and to £0.94m the year before that.

The operating profit from continuing business in the period was £1.0m, compared to £1.63m in the prior period. There are no items being highlighted in either the current reporting period or the same period last year.

The net interest charge rose to £1.8m (2016 £1.6m), resulting in a loss before tax of £0.81m for the six months to December 2017 (2016: profit before tax £0.03m).

The tax charge in the period was £0.4m (2016 £0.31m), relating to corporation tax on profits in India, New Zealand and Australia.

There were discontinued operations in the current period in Woodspeen Training, which is the final run-off of its Southern England operations, resulting in a £46k loss after tax (2016: Loss after tax of £5k).

 

Cash flow, net debt and facilities

Cash generated from operations in the period was £0.39m (2016: £0.38m).The Group generates operating cash flow from its product sales, and service maintenance contracts. Capital expenditure was £0.12m (2016: £0.30m) on Property Plant and Equipment and £0.02m (2016: £0.03m) on product development. In the prior year there was the final £0.68m deferred payment for the acquisition of Starkstrom, but there is no such item this year.

Repayments on financing activities on borrowings and interest were £0.9m whereas last year on the contrary net new loans and interest were £0.1m.

At the balance sheet date the Group's debt facilities, including unpaid interest, comprised £0.3m of invoice discounting facility (2016 £1.14m) and £27.2m of shareholder loans (including convertible loan notes) (2016 £24.3m).

At the same date the Group's cash and cash equivalents amounted to £2.37m (2016 £2.93m).

 

Shareholder loans

The Group's acquisitions have been funded in recent years entirely through the issue of 12% loan notes which are listed on the Channel Islands Stock Exchange.

The subscriber for all these notes has been DNY Investments Limited, a company which is an asset of the DNY Trust, a family trust of which Wayne Bos, Executive Chairman, is a discretionary beneficiary and of which Praxis Trustees Limited, the company's controlling shareholder, is trustee. Praxis Trustees remain supportive of the Group's strategy.

 

Dividend

The Board does not recommend a dividend for the period ended 31 December 2017. Given the Group's strategic direction and historic financial performance, the Board does not envisage the Company's paying a dividend for the foreseeable future.

 

 

Financial Structure

Whilst continuing to pursue our strategic objectives, to reduce costs and increase revenues, and to improve performance across all areas of the business, we are also looking to address the Group financial structure to meet the Group's future needs and will report to shareholders as and when appropriate.

Overall, we will continue to pursue our strategic objectives, seek means to reduce costs and increase revenues, and to improve performance across all areas of the business. There have been important changes in the leadership of the individual businesses which will drive forward positive changes in performance.

The second half of the year is expected to be impacted by the continuing focus on operational controls and efficiencies. The changes in the leadership in the individual business units are however not expected to show benefits until the next financial year.

 

 

By order of the Board

 

 

 

 

 

 

Wayne M Bos

Executive Chairman

 

28 March 2018

 

 

Unaudited consolidated statement of Comprehensive Income for the six months ended 31 December 2017

 

 

Unaudited six months ended 31.12.2017

Unaudited six months ended 31.12.2016

Audited year ended 30.06.17

 

 

 

 

 

 

 

 

 

Continuing operations

Note

£000

£000

 

£000

 

 

 

 

 

 

 

 

 

Revenue

3

 

33,244

 

36,486

74,682

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

(21,917)

 

(23,750)

(50,141)

 

 

Gross profit

 

11,327

12,736

 

24,541

 

 

 

 

 

 

 

 

 

Administrative and distribution expenses - excluding highlighted items

 

(10,320)

(11,108)

(22,095)

 

 

Administrative and distribution expenses - highlighted items

 

-

-

1,000)

 

 

Total administrative and distribution expenses

 

(10,320)

(11,108)

(21,095)

 

 

 

 

 

 

 

 

 

Operating (loss)/profit before highlighted items

 

1,007

1,628

2,446

 

 

Highlighted items

 

-

-

1,000

 

 

Operating (loss)/profit

 

1,007

1,628

3,446

 

 

 

 

 

 

 

 

 

Finance income

 

57

74

132

 

 

Finance costs

 

(1,873)

(1,674)

(3,458)

 

 

 

 

 

 

 

 

 

(Loss)/profit before tax and highlighted items

 

(809)

28

(880)

 

 

Highlighted items

 

-

-

1,000

 

 

 

 

 

 

 

 

 

(Loss)/profit before tax

 

(809)

28

120

 

 

 

 

 

 

 

 

 

Tax charge

 

(416)

(306)

(568)

 

 

(Loss)/profit after tax

 

(1,225)

(278)

(448)

 

 

 

 

 

 

 

 

 

Discontinued operation

 

 

 

 

 

 

(Loss)/profit after tax from discontinued operations

4

(46)

(5)

 

1

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period attributable to equity shareholders

 

(1,271)

(283)

 

(447)

 

 

 

 

 

 

 

 

 

Items that may be reclassified to profit or loss

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation differences on foreign operations

 

(222)

440

 

600

 

 

 

 

 

 

 

 

 

Other comprehensive income, net of tax

 

(222)

440

600

 

 

 

 

 

 

 

 

 

Total comprehensive (loss)/profit

 

(1,493)

157

 

153

 

 

 

 

 

 

 

 

 

(Loss)/earnings per share restated

 

 

 

 

 

 

Basic and Diluted

5

(79.55)p

(17.38)p

(28.02)p

 

 

 

 

 

 

 

 

 

 

Unaudited consolidated statement of Financial Position as at 31 December 2017

 

 

 

 

 

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

As at 31.12.2017

 

As at 31.12.2016

 

As at 30.6.2017

 

 

£000

 

£000

 

£000

Assets

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

785

 

1,097

 

937

Intangible assets

 

19,423

 

19,527

 

19,535

Deferred tax asset

 

806

 

839

 

825

Total non-current assets

 

21,014

 

21,463

 

21,297

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Inventories

 

3,942

 

4,389

 

3,927

Trade and other receivables

 

17,814

 

18,040

 

17,837

Other current assets

 

3,313

 

3,288

 

3,088

Tax receivable

 

-

 

-

 

-

Cash and cash equivalents

 

2,374

 

2,930

 

3,305

Total current assets

 

27,443

 

28,647

 

28,157

 

 

 

 

 

 

 

Total assets

 

48,457

 

50,110

 

49,454

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

(24,473)

 

(24,071)

 

(23,797)

Deferred consideration

 

-

 

-

 

-

Provisions

 

(2,127)

 

(2,694)

 

(2,144)

Tax liabilities

 

(624)

 

(205)

 

(443)

Bank and shareholder loans

 

(707)

 

(1,521)

 

(1,261)

Total current liabilities

 

(27,931)

 

(28,491)

 

(27,645)

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Shareholder loans

 

(19,513)

 

(19,039)

 

(19,302)

Deferred tax liability

 

(186)

 

(217)

 

(186)

Provisions

 

(99)

 

(142)

 

(100)

Total non-current liabilities

 

(19,798)

 

(19,398)

 

(19,588)

 

 

 

 

 

 

 

Total liabilities

 

(47,729)

 

(47,889)

 

(47,233)

 

 

 

 

 

 

 

Net assets

 

728

 

2,221

 

2,221

 

 

 

 

 

 

 

Issued share capital

 

19,967

 

19,967

 

19,967

Share premium

 

114

 

114

 

114

Other reserve

 

75

 

75

 

75

Merger reserve

 

(14,854)

 

(14,854)

 

(14,854)

Own shares in trust

 

(2)

 

(2)

 

(2)

Share option reserve

 

57

 

47

 

57

Retained earnings

 

(5,338)

 

(3,897)

 

(4,067)

Foreign currency translation reserve

 

709

 

771

 

931

Total equity

 

728

 

2,221

 

2,221

 

 

 

 

Unaudited consolidated Cash Flow Statement for the six months ended 31 December 2017

 

 

Unaudited

Unaudited

Audited

 

 

Six months ended 31.12.2017

Six months ended 31.12.2016

Year ended

30.6.2017

 

 

 

 

 

 

 

£000

£000

£000

Operating profit/(loss)

 

961

1,623

3,446

 

 

 

 

 

Adjustments for:

 

 

 

 

Depreciation and amortisation

 

351

395

743

Loss on fixed asset disposal

 

-

-

-

Impairment of intangibles

 

-

-

-

Gain on bargain purchase

 

-

-

-

Share option charge

 

-

11

22

(increase) in inventories

 

(57)

(949)

(499)

(increase) in trade and other receivables

 

(563)

(2,314)

(2,077)

Increase/(decrease) in trade and other payables

 

(200)

1,755

(276)

Exchange difference on consolidation

 

(97)

(142)

31

Cash generated from operations

 

395

379

1,390

 

 

 

 

 

Income tax paid

 

(227)

(360)

(357)

 

 

 

 

 

Net cash generated from operations

 

168

19

1,033

 

 

 

 

 

Investing activities

 

 

 

 

Interest received

 

57

73

132

Purchases of property and equipment

 

(121)

(305)

(465)

Capitalised expenditure on product development

 

(17)

(28)

(80)

Acquisition of subsidiaries (net of cash acquired)

 

-

(681)

(681)

Net cash used in investing activities

 

(81)

(941)

(1,094)

 

 

 

 

 

Financing activities

 

 

 

 

Proceeds from borrowings

 

-

191

-

Repayment of borrowings

 

(611)

-

(347)

Interest costs paid

 

(352)

(88)

(28)

Net cash from financing activities

 

(963)

103

(375)

 

 

 

 

 

Net change in cash and cash equivalents

 

(876)

(819)

(436)

 

 

 

 

 

Cash and cash equivalents at start of period

 

3,305

3,564

3,564

Foreign exchange rate differences

 

(55)

185

177

Cash and cash equivalents at end of period

 

2,374

2,930

3,305

 

 

 

 

 

Cash and cash equivalents comprise:

 

 

 

 

Cash in hand and at bank

 

2,374

2,930

3,305

Bank overdraft

 

-

-

-

 

 

2,374

2,930

3,305

 

 

 

 

 

 

 

 

Unaudited consolidated Statement of Changes in Equity for the six months ended 31 December 2017

 

Called up share capital

Share premium account

Other reserve

Merger reserve

Ownshares in trust

Share option reserve

Foreign currency translation reserve

Retained earnings

Total

Group

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

 

 

As at 30.6.2016

19,967

114

75

(14,854)

(2)

42

331

(3.620)

2,053

Options granted

-

-

-

-

-

11

-

-

11

Options lapsed and waived

-

-

-

-

-

(6)

-

6

-

Transactions with owners

-

-

-

-

-

5

-

6

11

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

-

-

-

(283)

(283)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

-

-

-

-

-

-

440

-

440

Total comprehensive income for the year

-

-

-

-

-

-

440

(283)

157

As at 30.12.2016

19,967

114

75

(14,854)

(2)

47

771

(3,897)

2,221

                  

 

 

 

Called up share capital

Share premium account

Other reserve

Merger reserve

Ownshares in trust

Share option reserve

Foreign currency translation reserve

Retained earnings

Total

Group

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

 

 

As at 30.6.2017

19,967

114

75

(14,854)

(2)

57

931

(4,067)

2,221

Options granted

-

-

-

-

-

-

-

-

-

Options lapsed and waived

-

-

-

-

-

-

-

-

-

Transactions with owners

-

-

-

-

-

-

-

-

-

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

-

-

-

(1,271)

(1,271)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

-

-

-

-

-

-

(222)

-

(222)

roundings

 

 

 

 

 

 

 

 

 

Total comprehensive income for the year

-

-

-

-

-

-

(222)

(1,271)

(1,493)

As at 30.12.2017

19,967

114

75

(14,854)

(2)

57

709

(5,338)

728

                  

 

 

 

 

 

 

Notes to the unaudited accounts:

1. Basis of preparation and accounting policies

These interim financial statements are for the six months ended 31 December 2017. They have been prepared based on the measurement and recognition principles of International Financial Reporting Standards as adopted by the European Union (EU-IFRS) and IFRC interpretations issued and effective at the time of preparing these statements. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the audited financial statements of Progility plc for the year ended 30 June 2017. The financial information for the period ended 31 December 2017 set out in this interim report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the period ended 30 June 2017 have been filed with the Registrar of Companies and can be found on the Group's website www.progility.com. The auditor's report on those financial statements was unqualified and did not contain statements under Section 498(2) or Section 498(3) of the Companies Act 2006. These interim financial statements have been prepared under the historical cost convention as modified by the revaluation of derivative financial instruments. These interim financial statements have been prepared in accordance with the accounting policies detailed in the Group's financial statements for the year ended 30 June 2017 except as documented herein. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of these interim financial statements. The interim financial statements are presented in Sterling (£), which is also the functional currency of the Company.

 

These interim financial statements have been approved for issue by the board of directors. It should be noted that accounting estimates and assumptions are used in preparation of the interim financial information. Although these estimates are based on management's best knowledge and judgement of current events and actions, actual results may ultimately differ from those estimates. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the interim financial information, are set out in note 2 to the interim financial information. In the future, actual experience may deviate from these estimates and assumptions.

 

The consolidated financial statements include the financial statements of Progility plc and its subsidiaries. There are no associates or joint ventures to be considered.

 

2. Accounting estimates and key judgements

The preparation of the interim financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the disclosure of contingent liabilities at the date of the financial statements. Such estimates and assumptions are based on historical experience and various other factors that are believed to be reasonable in the circumstances and constitute management's best judgment of conditions at the date of the financial statements. Key estimates and judgments relate to impairment analysis assumptions, revenue recognition over exam vouchers, stock movement and deferred tax assets. In the future, actual experience may deviate from these estimates and assumptions, which could affect the interim financial statements as the original estimates and assumptions are modified, as appropriate, in the period in which the circumstances change.

 

Key judgement - Goodwill

In respect of acquisitions, the Group measures goodwill at the acquisition date as:

· The fair value of the consideration transferred; plus the recognised amount of any non-controlling interests in the acquired; plus

· The fair value of the existing equity interest in the acquiree; less

· The net recognised amount (generally fair value) of the identifiable assets acquired and liabilities assumed.

When the excess is negative, the negative goodwill is recognised immediately in the profit and loss. Costs related to the acquisition, other than those associated with the issue of debt or equity securities, are expensed as incurred.

 

 

Key judgement - Going concern

The Directors, after making enquiries of its loan note holders, considering its financing arrangements and based on its cash flow projections, have a reasonable expectation that the Company and the Group will have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and financial statements.

 

3. Segmental reporting

 

In accordance with IFRS 8 the Group's operating segments are based on the reports reviewed by the Executive Directors that are used to make strategic decisions.

 

The Group reports its results in three segments:-

 

Professional Services - The Group's Professional operations comprise the training, recruitment and consultancy activities operating in the UK, Dubai, Australia and New Zealand.

 

Healthcare - The Group's Health operations comprise the activities of Starkstrom Limited.

 

Communications - The Group's Communications operations comprise the technology solutions goods and services businesses which operate in Australia and India.

 

Central corporate costs comprise Head Office functions, including Finance, Treasury and Human Resources

 

Segment profit or loss consists of earnings before interest, tax and highlighted items. This measurement excludes the effects of non-recurring expenditure from the operating segments such as restructuring costs and purchased intangibles amortisation. Interest income and expenditure are not allocated to segments as this type of activity is driven by the central treasury activities, which manages the cash position of the Group.

 

 

 

 

Six months ended 31.12.2017

Six months ended31.12.2016

Year ended30.6.2017

 

Revenue

Segment Profit/ (loss)

Revenue

Segment Profit/ (loss)

Revenue

Segment Profit/ (loss)

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

Professional services

7,113

580

7,719

737

15,726

1,278

Healthcare

6,455

140

6,255

622

14,281

1,433

Communications

19,718

642

22,810

831

45,091

688

Elimination of Professional Services discontinued operations

(42)

46

(298)

5

(416)

(1)

Central corporate costs

 

(401)

 

(567)

 

(952)

 

 

 

 

 

 

 

Total segmental result

33,244

1,007

36,486

1,628

74,682

2,446

 

 

 

 

 

 

 

Highlighted items

 

-

 

-

 

1,000

Operating profit from continuing operations

 

1,007

 

1,628

 

3,446

Net finance costs

 

(1,816)

 

(1,600)

 

(3,326)

Profit before tax from continuing operations

 

(809)

 

28

 

120

 

 

 

 

 

 

 

Adjusting for highlighted items

 

 

 

 

 

 

Reversal of provisions - Non-recurring,

 

-

 

-

 

(1,000)

Impairment charges - Non-recurring

 

-

 

-

 

-

 

 

-

 

-

 

(1,000)

 

 

As at 31.12.2017

As at 31.12.2016

As at 30.6.2017

 

 

 

 

 

 

Segmental assets

Segmental liabilities

Segmental assets

Segmental liabilities

Segmental assets

Segmental liabilities

 

£'000

£'000

£'000

£'000

£'000

£'000

Professional services

24,470

26,820

22,052

24,979

23,021

26,486

Healthcare

4,950

3,690

3,510

3,757

3,746

3,791

Communications

19,037

17,219

24,548

19,153

22,687

16,956

 

 

 

 

 

 

 

Total

48,457

47,729

50,110

47,889

49,454

47,233

 

 

 

 

 

 

 

 

 

4. Discontinued operations

 

In February 2016, Woodspeen Training Limited, part of the Group's Professional Services sector, decided to discontinue operations in the south of England and provide all training services in the north of the country. The revenues, expenses and pre-tax profit of the discontinued operations for the current period and the prior period are detailed below.

 

 

 

 

Six months ended 30.12.2017

Six months ended 30.12.2016

 

£'000

£'000

Revenue

42

298

Expenses

(88)

(303)

Pre-tax loss

(46)

(5)

Taxation

-

-

Post-tax loss

(46)

(5)

 

 

 

Basic and diluted loss per share from discontinued operations

-

-

 

5. Loss per share

 

This has been calculated on the loss for the period of £1,070,631 (2016: Loss £283,000) and the number of shares used was 1,597,332 as restated (2016: 1,597,332), being the restated number of share in issue at the end of the period.

The ordinary shares were reorganized on 22 Dec 2017 with 199,666,880 shares of £0.10 being converted into 399,333 of £50 each, which were then amended to become 1,597,332 ordinary shares of £0.0025 and 399,333 deferred shares of £49.99.

Consequently at 31 Dec 2017 the number of ordinary shares now in issue is 1,597,332.

 

 

6. Dividends

 

No dividend is proposed for the six months ended 31 December 2017.

 

7. Loan Notes

 

The unsecured convertible 12 % loan notes issued by Progility Plc with a redemption date of 31.12.2017 have been varied to extend the redemption date to 31.12.2019 on the same terms as the original agreement.

 

8. Copies of Interim financial statements

 

The Interim Results will be posted on the Company's web site www.progility.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUAAWUPRGQR
Date   Source Headline
16th Jul 20185:30 pmRNSProgility
10th Jul 201811:06 amRNSResult of General Meeting and Cancellation
22nd Jun 20186:17 pmRNSCANCELLATION OF ADMISSION TO TRADING ON AIM
29th Mar 20187:00 amRNSInterim Results
10th Jan 20184:11 pmRNSExtension of Convertible Loan Note
22nd Dec 201710:37 amRNSResults of AGM and update on Share reorganisation
28th Nov 20177:50 amRNSPosting Accounts, AGM Notice, Share Reorganisation
24th Nov 20173:59 pmRNSFinal Results
13th Oct 201710:33 amRNSNotice of Results - update
11th Sep 20173:31 pmRNSStatement re share price movement & Results Notice
23rd Mar 20177:00 amRNSInterim Results
15th Nov 20165:42 pmRNSResult of AGM
21st Oct 201610:35 amRNSAnnual Report & Accounts Publication & AGM Notice
7th Oct 201611:06 amRNSFinal Results
27th Sep 20162:31 pmRNSAnnouncement of Final Results
16th Sep 20161:40 pmRNSStatement regarding share price movement
12th Sep 20161:36 pmRNSChange of Registered Office
15th Apr 20162:26 pmRNSResignation of Director
1st Apr 201611:40 amRNSNew Loan Agreement & loan maturity date extension
24th Mar 20167:00 amRNSInterim Results
24th Feb 20167:00 amRNSIssue of Loan Notes
28th Oct 20153:52 pmRNSResults of the Annual General Meeting
26th Oct 20157:19 amRNSCareShield option waived by mutual consent
2nd Oct 20152:00 pmRNSAnnual Report & Accounts and Notice of AGM
24th Sep 20158:47 amRNSIssue of Loan Notes
22nd Sep 20157:00 amRNSFinal Results
23rd Jul 20151:47 pmRNSDirectorate Change
15th Jul 20151:21 pmRNSRepayment of Vendor Loan Notes
29th Jun 20157:00 amRNSPre-close trading statement
18th Jun 20159:39 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Jun 20157:00 amRNSGrant of Share Options
28th May 201510:55 amRNSDirector's dealings
27th Apr 20157:00 amRNSIssue of Loan Notes
30th Mar 201511:00 amRNSDirector's Dealings
27th Mar 20157:30 amRNSBoard Changes
27th Mar 20157:15 amRNSIssue of Loan Notes
27th Mar 20157:00 amRNSInterim Results for 6 months to 31 December 2014
9th Mar 20157:00 amRNSDirector's Resignation
15th Jan 20157:00 amRNSRepayment of Vendor Loan Notes
5th Jan 20154:43 pmRNSAcquisition
30th Dec 201410:10 amRNSAcquisition
19th Dec 20147:00 amRNSAcquisition
18th Dec 201412:48 pmRNSAcquisition of Woodspeen Training Limited
17th Dec 20147:00 amRNSListing of Loan Notes
5th Nov 201412:00 pmRNSResult of AGM
24th Oct 201411:30 amRNSGrant of Share Options
13th Oct 20145:28 pmRNSAnnual Report & Accounts and Notice of AGM
30th Sep 20147:00 amRNSFinal Results
17th Jul 20145:06 pmRNSDirector/PDMR Shareholding
17th Jul 201412:35 pmRNSDirector's Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.